Bayer’s heart failure drug bound for NHS on NICE recommendation
The UK's National Institute for Health and Care Excellence (NICE) has recommended Bayer's non-steroidal heart failure drug, Kerendia (finerenone), for use in the National Health Service (NHS), as the condition remains one of the leading causes of …